Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers.

Marie-Lise Colsoul, Nicolas Goderniaux, Sabrina Onorati, Stéphanie Dupuis, Jacques Jamart, Dominique Vanpee, Ivan Berlin, Laurence Galanti

Clinical biochemistry 2023 Jun

filter terms:

Anatabine and anabasine are two tobacco alkaloids used to differentiate between tobacco users and abstainers, including users of nicotine replacement therapy. Cutoff values (>2 ng/mL for both alkaloids) have not been revised since their implementation in 2002. These values may be too high, leading to increased likelihood of misclassification between smokers and abstainers. This results in major consequences, especially adverse outcomes of transplantation when smokers were incorrectly identified as being abstinent. This study proposes that a lower threshold for anatabine and anabasine will better distinguish tobacco users from non-users and thereby improve patients' care. A new and more sensitive analytical method by liquid chromatography-mass detection was developed to allow the quantification of low concentrations. Anatabine and anabasine were measured in urine samples of 116 self-reported daily smokers and 47 long-term non-smokers (confirmed by the analysis of nicotine and its metabolites). The best compromise between sensitivity and specificity allowed us to determine new cutoff values. The thresholds >0.097 ng/mL for anatabine and >0.236 ng/mL for anabasine were associated with a sensitivity of 97% (anatabine) and 89% (anabasine) and a specificity of 98% for both alkaloids. These cutoff values greatly increased the sensitivity given that it dropped to 75% (anatabine) and 47% (anabasine) when using the reference value (>2 ng/mL). The cutoff values >0.097 ng/mL for anatabine and >0.236 ng/mL for anabasine appear to better differentiate tobacco users from abstainers than the current reference threshold (>2 ng/mL for both alkaloids). It may considerably impact patients' care, especially in transplantation settings in which smoking abstinence is essential to avoid adverse outcomes of transplantation. Copyright © 2023 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Citation

Marie-Lise Colsoul, Nicolas Goderniaux, Sabrina Onorati, Stéphanie Dupuis, Jacques Jamart, Dominique Vanpee, Ivan Berlin, Laurence Galanti. Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers. Clinical biochemistry. 2023 Jun;116:128-131